Why did Medicus Pharma's operating expenses surge in Q4 2024?

Medicus Pharma's operating expenses increased by 1.1% in Q4 2024, primarily due to an increase in channel expenses. The company's focus on expanding its market reach and distribution network could be a significant factor in the rise of operating expenses. Additionally, the company's recent achievements, such as receiving the Minor Use in Major Species (MUMS) designation for its D-MNA patch from the U.S. FDA, may have also contributed to the increased expenses associated with marketing and promotional activities.